Company Analysis
Sign in

iRadimed Corporation (IRMD)

Nasdaq: IRMD · Surgical & Medical Instruments & Apparatus · Orlando, FL · filing with the SEC since 2005
Full chart Alerts Compare
Grade6.5
◀ Past 5.4● Present 7.4▶ Future 6.6
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2025, as filed
Revenue$83.8M+14.4%
Net income$22.5M+16.9%
Earnings per share$1.75+16.7%
Operating cash flow$24.9M-2.6%
Cash$51.2M-2.1%
Debtn/a
Shareholders’ equity$94.6M+9.0%
Shares, diluted12.9M+0.5%
Return on equity23.8%
The recordfrom its filings
Filings in 202645
Newest filingOct 30 · 10-Q
Annual reportMar 6, 2026
Quarterly reportOct 30, 2026
Next report due10-K by Mar 31
Insider sales, 12 months$20.7M
Insider buys, 12 months$0.00
Patents granted20
Filer categoryNon-accelerated filer<br>Smaller reporting company
Trailing twelve months to Sep 2026Revenue $89.3MNet income $24.0MCash from operations $27.1Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
16171819202122232425
As filed, in USD. Nothing here is a forecast.

News

Oct 30, 2026 · SEC EDGAR · Form 10-Q
Quarterly report
Open the filing on sec.gov
Oct 30, 2026 · SEC EDGAR · Form 8-K
Results released
Open the filing on sec.gov
Sep 25, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Sep 8, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Jul 31, 2026 · SEC EDGAR · Form 10-Q
Quarterly report
Open the filing on sec.gov
Jul 31, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Jul 28, 2026 · SEC EDGAR · Form SCHEDULE 13G
Large holder notice
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton IRMD · research, not advice